GLP-1s were first approved in 2005 for the treatment of Type 2 diabetes. Since then, more versions of the medication have hit the market, becoming more accessible to patients and used for a wider ...

From vaccines to sedatives, not all accidental injections are minor. Here's what you need to know about recognizing risk and seeking care.

Zepbound KwikPen, a 4-dose single-patient delivery device for tirzepatide administration has been made available by Lilly.

Submit an appeal, even if you're worried you’ll lose. Yaver said that, based on the research set to be published in her book, Coverage Denied: How Health Insurers Drive Inequality in the United States ...

TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...

Empower Pharmacy could be banned from doing business in California after the state's pharmacy board moved to revoke Empower’s ...

Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...

The Tennessee Poison Center is seeing a sharp increase in calls related to tirzepatide and semaglutide exposure — two ...

The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: Tirzepatide with B12 is sometimes combined as a weekly injection for weight loss. Vitamin … ...

The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...